Figure 3.

Effect of treatment with the dual analog on the grip strength of mice. Individual mice of three groups: (i) Control mice injected with PBS/CFA, (ii) mice with EAMG manifestations that were treated with PBS, and (iii) mice with EAMG that were treated with the dual analog given orally in PBS, were subjected to evaluation using a grip strength meter (see Materials and Methods). Results are of mice tested after 4 wk of treatment. Results are expressed as maximum grip strength of five successive repeated and recorded measurements. Dashes indicate the mean maximal grip strength per group. The group treated with the dual analog differs significantly (P < 0.01) from the PBS-treated group.